PINEOBLASTOMA
Clinical trials for PINEOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new PINEOBLASTOMA trials appear
Sign up with your email to follow new studies for PINEOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with brain cancer: triple therapy trial launches
Disease control Recruiting nowThis early-phase study tests a new drug (SGT-53) combined with radiation and immunotherapy (Nivolumab) for children whose brain tumors have returned or not responded to standard treatments. The goal is to find a safe dose and understand side effects. Up to 18 children with specif…
Matched conditions: PINEOBLASTOMA
Phase: EARLY_PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated May 26, 2026 05:15 UTC
-
Engineered immune cells target deadly childhood brain tumors
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and young adults with medulloblastoma or other rare brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack a protein calle…
Matched conditions: PINEOBLASTOMA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
Tailored immune cells take on childhood brain cancer in first human test
Disease control Recruiting nowThis early-phase study tests whether a personalized immune cell treatment is safe for children under 5 with certain brain tumors. The treatment uses the child's own immune cells, trained to attack unique markers from their tumor. Up to 12 children will receive the therapy after s…
Matched conditions: PINEOBLASTOMA
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New hope for toddlers with rare brain cancers: targeted chemo combo under study
Disease control Recruiting nowThis early-phase study tests whether adding a chemotherapy drug (topotecan) given into the spinal fluid, followed by maintenance chemo, is safe and feasible for children under 6 with high-risk embryonal brain tumors. The goal is to improve cancer control after standard high-dose …
Matched conditions: PINEOBLASTOMA
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated May 18, 2026 12:03 UTC